Is population-level perversity a likely outcome of mass vaccination against HIV?

Lancet Infectious Diseases

Volumn 5, Issue 5, 2005, Pages 254-256

  Bogaards, Johannes A ^a   Van Ballegooijen, W Marijn ^b   Weverling, Gerrit Jan ^a   Boerlijst, Maarten C ^b   Goudsmit, Jaap ^a,c,d   Blower, Sally M ^e,f   Smith, Robert J ^e  

^a University of Amsterdam ^*

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

COUNSELING; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; NOTE; OUTCOMES RESEARCH; POPULATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SURVIVAL; VACCINATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 18044387620     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70089-X     Document Type: Letter

References (5)

1. RJ Smith SM Blower Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis 4 2004 636 639
2. M van Ballegooijen JA Bogaards GJ Weverling MC Boerlijst J Goudsmit AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination J Acquir Immune Defic Syndr 34 2003 214 220
3. J Goudsmit JA Bogaards S Jurriaans Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia AIDS 16 2002 791 793
4. DH Barouch NL Letvin HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines? Lancet 364 2004 10 11
5. MP Davenport RM Ribeiro DL Chao AS Perelson Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus J Virol 78 2004 11340 11351